Literature DB >> 12270507

Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase.

Z Xu1, F J Seidler, M M Cousins, W Slikker, T A Slotkin.   

Abstract

Nicotine is a neuroteratogen that targets synaptic function during critical developmental stages and recent studies indicate that CNS vulnerability extends into adolescence, the age at which smoking typically commences. We administered nicotine to adolescent rats via continuous minipump infusions from PN30 to PN47.5, using 6 mg/kg/day, a dose rate that replicates the plasma nicotine levels found in smokers, and examined 5HT receptors and related cell signaling during nicotine administration (PN45) and in the post-treatment period (PN50, 60, 75). Adolescent nicotine decreased 5HT(2) receptor binding in brain regions containing 5HT projections (hippocampus and cerebral cortex), with selectivity for females in the cerebral cortex; regions containing 5HT cell bodies showed either an increase (midbrain in males) or no change (brainstem). In contrast, there were no significant changes in 5HT(1A) receptors; however, the ability of the receptors to signal through adenylyl cyclase (AC) showed a switch from stimulatory to inhibitory effects in females during the post-treatment period. There were also transient alterations in AC responses to beta-adrenergic receptor stimulation, as well as pronounced induction of the AC response to the non-receptor-mediated stimulant, forskolin. Our results indicate that adolescent nicotine exposure alters the concentrations and functions of postsynaptic 5HT receptors in a manner commensurate with impaired 5HT synaptic function. The direction of change, emergence of defects after the cessation of nicotine administration, and sex-preference for effects in females, all support a relationship of impaired 5HT function to the higher incidence of depression seen in adolescent smokers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12270507     DOI: 10.1016/s0006-8993(02)03174-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.

Authors:  David A Connor; Thomas J Gould
Journal:  Neuropharmacology       Date:  2017-08-02       Impact factor: 5.250

2.  Age-dependent effects of initial exposure to nicotine on serotonin neurons.

Authors:  S J Bang; K G Commons
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 3.  Differential effects of psychoactive drugs in adolescents and adults.

Authors:  Sari Izenwasser
Journal:  Crit Rev Neurobiol       Date:  2005

4.  Increased nicotine self-administration following prenatal exposure in female rats.

Authors:  Edward D Levin; Susan Lawrence; Ann Petro; Kofi Horton; Frederic J Seidler; Theodore A Slotkin
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

Review 5.  Neurobiological processes in adolescent addictive disorders.

Authors:  Ty S Schepis; Bryon Adinoff; Uma Rao
Journal:  Am J Addict       Date:  2008 Jan-Feb

Review 6.  Cellular events in nicotine addiction.

Authors:  Rachel E Penton; Robin A J Lester
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

Review 7.  Adolescent brain maturation and smoking: what we know and where we're headed.

Authors:  David M Lydon; Stephen J Wilson; Amanda Child; Charles F Geier
Journal:  Neurosci Biobehav Rev       Date:  2014-07-12       Impact factor: 8.989

8.  Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: effects on serotonin systems in adolescence and adulthood.

Authors:  Theodore A Slotkin; Ian T Ryde; Edward D Levin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2007-11-12       Impact factor: 4.077

9.  Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke.

Authors:  Robyn M Amos-Kroohs; Michael T Williams; Amanda A Braun; Devon L Graham; Cynthia L Webb; Todd S Birtles; Robert M Greene; Charles V Vorhees; M Michele Pisano
Journal:  Neurotoxicol Teratol       Date:  2013-01-11       Impact factor: 3.763

10.  Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats.

Authors:  Andrew E Arrant; Elizabeth Coburn; Jacob Jacobsen; Cynthia M Kuhn
Journal:  Neuropharmacology       Date:  2013-06-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.